KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Capital Expenditures (2016 - 2025)

Maxlinear (MXL) has disclosed Capital Expenditures for 16 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 69.08% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.6 million, a 28.74% decrease, with the full-year FY2025 number at $12.6 million, down 28.74% from a year prior.
  • Capital Expenditures was $3.7 million for Q4 2025 at Maxlinear, down from $5.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $16.6 million in Q4 2022 to a low of $1.2 million in Q2 2025.
  • A 5-year average of $6.2 million and a median of $5.1 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: skyrocketed 494.4% in 2021, then plummeted 92.34% in 2023.
  • Maxlinear's Capital Expenditures stood at $12.2 million in 2021, then skyrocketed by 35.83% to $16.6 million in 2022, then tumbled by 92.34% to $1.3 million in 2023, then soared by 72.14% to $2.2 million in 2024, then surged by 69.08% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's Capital Expenditures are $3.7 million (Q4 2025), $5.7 million (Q3 2025), and $1.2 million (Q2 2025).